English: Now, huge strides have been made in medicine, as Lynne outlined, and in other cancers like childhood leukaemia, Hodgkin's disease and many other cancers, as outlined, survival rates have been dramatically, radically transformed over the years. All of those conditions did have a particular focus at the time, though, in terms of we said at the time, 'Childhood leukaemia: why are children dying? Let's have a particular focus on that. Let's sort it out.' That was 25 years ago, now. But, it hasn't happened for pancreatic cancer, and that's why we're having this debate today. The distressing case studies that we've heard from Lynne, from Delyth, from Neil McEvoy and others demand action and a focus on pancreatic cancer. And by demanding focus, we mean that 'focus' means increased funding for this particular cancer, and it does actually mean serious consideration, and I would be campaigning to set up this specialist tertiary surgical centre. I think that is the transformational element that needs to happen. As the Minister said, surgery is curative, so let's enable the very best surgery targeted at this hugely malignant cancer. That single hepatobiliary pancreatic surgical centre needs to happen. That is the transformative action; that is the fast-track surgery; that's the early diagnosis; that's what needs to happen. Because it is really tough to diagnose this. People present with really vague symptoms that could be anything or nothing, as Delyth said in her distressing case involving mam-gu. It is hugely difficult to pick up the signs, because we can't, as GPs refer everybody who comes along with a bit of tummy pain and not feeling well and feeling a bit off colour, otherwise our hospitals would be full - [ Interruption.] They are. And diagnostic tests to improve research have worked for other conditions that we thought never had a diagnostic test. That's why the emphasis is on research here, as well, to find that test. So, I'm grateful to David Melding as well for paying tribute to Pancreatic Cancer UK, a tribute to their great work. Much research is going on and it's research that will transform the field. People say, 'You're always talking about research, it's a bit tedious', but that's where all these medical advances have come about. Tremendous research enables medical technology, medical treatments, and medical advances to truly take off. Cancer Research UK, Cancer Research Wales - everybody is doing a phenomenal amount of innovative research. And Delyth reminded us that November is Pancreatic Cancer Awareness Month, and again, emphasising the trauma of the diagnosis, and the need for a national plan, as we're already saying - this national focus uniquely for pancreatic cancer. I'm grateful also to Caroline Jones for her personal experience and her support for this motion, and also for Neil McEvoy's words on the fast-track surgery, and his personal experience. I'm grateful to the Minister as well, before closing, in terms of, obviously acknowledging the excellent work that is done by our excellent staff in the NHS at the moment. Improvements are happening, but, uniquely for pancreatic cancer, we still haven't seen that step change in survival rates. So, we have to have that focus on funding, on that setting up of a single hepatobiliary pancreatic surgical centre; I look forward to the day - the Minister could even open it. We need a focus. I hear the words about the single cancer pathway - absolutely fantastic - but within that, there needs to be a particular emphasis on what we can do about this silent, and not-so-silent killer, that is pancreatic cancer. So, cancer of the pancreas - in closing, Deputy Presiding Officer - demands a particular focus. It's had a particular focus here in the Chamber this afternoon. I am grateful for the contribution of all Members. Yes, we can learn from other countries, other centres, we can learn from the rapid diagnosis pilots. We need to take all that on board but also work and step up to the challenge and support the motion. Diolch yn fawr.
Welsh: Nawr, gwnaed camau breision mewn meddygaeth, fel yr amlinellodd Lynne, ac mewn canserau eraill megis lewcemia plant, clefyd Hodgkin a nifer o ganserau eraill, fel y'u hamlinellwyd, mae cyfraddau goroesi wedi cael eu trawsnewid yn ddramatig ac yn radical dros y blynyddoedd. Roedd ffocws penodol i bob un o'r cyflyrau hynny ar y pryd, er, o ran yr hyn a ddywedasom ar y pryd, 'Lewcemia plant: pam y mae plant yn marw? Gadewch i ni ganolbwyntio'n benodol ar hynny. Gadewch i ni ei ddatrys.' Roedd hynny 25 mlynedd yn ôl bellach. Ond nid yw wedi digwydd ar gyfer canser y pancreas, a dyna pam ein bod yn cael y ddadl hon heddiw. Mae'r astudiaethau achos trallodus a glywsom gan Lynne, gan Delyth, gan Neil McEvoy ac eraill yn galw arnom i weithredu a rhoi ffocws ar ganser y pancreas. A thrwy fynnu ffocws, yr hyn a olygwn yw fod 'ffocws' yn golygu mwy o gyllid ar gyfer y canser penodol hwn, ac mae'n golygu ystyriaeth ddifrifol mewn gwirionedd, a buaswn yn ymgyrchu i sefydlu'r ganolfan lawfeddygol drydyddol arbenigol hon. Credaf mai dyna'r elfen drawsnewidiol y mae angen iddi ddigwydd. Fel y dywedodd y Gweinidog, mae llawdriniaeth yn iachaol, felly gadewch i ni alluogi'r llawdriniaeth orau un i dargedu'r canser hynod falaen hwn. Mae angen i'r un ganolfan lawfeddygaeth hepatobiliari bancreatig honno ddigwydd. Y camau trawsnewidiol; y llawdriniaeth llwybr carlam; y diagnosis cynnar; mae angen i hynny ddigwydd. Oherwydd mae'n anodd iawn gwneud diagnosis o'r clefyd hwn. Mae gan bobl symptomau amwys iawn a allai fod yn unrhyw beth neu'n ddim byd, fel y dywedodd Delyth yn ei hanes gofidus am ei mam-gu. Mae'n hynod o anodd nodi'r arwyddion, oherwydd fel meddygon teulu ni allwn atgyfeirio pawb sy'n dod atom gydag ychydig o boen bol ac sy'n teimlo'n anhwylus, fel arall byddai ein hysbytai'n llawn - [ T orri ar draws.] Maent yn llawn. Ac mae profion ymchwil i wella diagnosteg wedi gweithio ar gyfer cyflyrau eraill nad oeddem erioed wedi meddwl y byddai prawf diagnostig ar eu cyfer. Dyna pam y mae'r pwyslais ar ymchwil yma i ddod o hyd i'r prawf hwnnw. Felly, rwy'n ddiolchgar i David Melding hefyd am dalu teyrnged i Pancreatic Cancer UK, teyrnged i'w gwaith gwych. Mae llawer o waith ymchwil yn mynd rhagddo ac mae'n ymchwil a fydd yn trawsnewid y maes. Mae pobl yn dweud, 'Rydych chi bob amser yn siarad am ymchwil, mae ychydig yn ddiflas', ond dyna lle mae'r holl ddatblygiadau meddygol hyn wedi digwydd. Mae ymchwil aruthrol yn galluogi technoleg feddygol, triniaethau meddygol, a datblygiadau meddygol i ddigwydd go iawn. Cancer Research UK, Ymchwil Canser Cymru - mae pawb yn gwneud llawer iawn o ymchwil arloesol. Ac fe'n hatgoffwyd gan Delyth fod mis Tachwedd yn Fis Ymwybyddiaeth Canser y Pancreas, ac eto, drwy bwysleisio trawma'r diagnosis, a'r angen am gynllun cenedlaethol, fel rydym yn ei ddweud yn barod - y ffocws cenedlaethol hwn yn benodol ar ganser y pancreas. Rwy'n ddiolchgar hefyd i Caroline Jones am ei phrofiad personol a'i chefnogaeth i'r cynnig hwn, ac am eiriau Neil McEvoy ar lawdriniaeth llwybr carlam, a'i brofiad personol. Rwy'n ddiolchgar i'r Gweinidog hefyd, cyn cloi, am gydnabod y gwaith rhagorol sy'n cael ei wneud gan ein staff rhagorol yn y GIG ar hyn o bryd wrth gwrs. Mae gwelliannau'n digwydd, ond yn unigryw yn achos canser y pancreas, nid ydym wedi gweld newid mawr yn y cyfraddau goroesi o hyd. Felly, mae'n rhaid i ni ganolbwyntio ar ariannu, ar sefydlu un ganolfan lawfeddygaeth hepatobiliari bancreatig; edrychaf ymlaen at y diwrnod - gallai'r Gweinidog ei hagor hyd yn oed. Mae angen ffocws arnom. Clywaf y geiriau am un llwybr canser - hollol wych - ond o fewn hynny, mae angen pwyslais arbennig ar yr hyn y gallwn ei wneud am y lladdwr tawel, a heb fod mor dawel, canser y pancreas. Felly, mae canser y pancreas - i gloi, Ddirprwy Lywydd - yn galw am ffocws penodol. Mae wedi cael ffocws penodol yma yn y Siambr y prynhawn yma. Rwy'n ddiolchgar am gyfraniad yr holl Aelodau. Gallwn, fe allwn ddysgu gan wledydd eraill, canolfannau eraill, gallwn ddysgu o'r cynlluniau peilot diagnosis cyflym. Mae angen inni ystyried hynny i gyd a gweithio hefyd ac ymateb i'r her a chefnogi'r cynnig. Diolch yn fawr.